Otsuka Holdings
4578.T
#617
Rank
โ‚น3.822 T
Marketcap
โ‚น7,296
Share price
1.74%
Change (1 day)
55.05%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Revenue for Otsuka Holdings (4578.T)

Revenue in 2026 (TTM): โ‚น1.586 Trillion

According to Otsuka Holdings 's latest financial reports the company's current revenue (TTM ) is โ‚น1.594 Trillion. In 2025 the company made a revenue of โ‚น1.482 Trillion an increase over the revenue in the year 2024 that were of โ‚น1.307 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Otsuka Holdings from 2010 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น1.586 T7.04%
2025 โ‚น1.482 T13.41%
2024 โ‚น1.307 T10.56%
2023 โ‚น1.182 T9.51%
2022 โ‚น1.079 T8.55%
2021 โ‚น994.56 B1.27%
2020 โ‚น982.04 B7.52%
2019 โ‚น913.39 B11.55%
2018 โ‚น818.79 B16.07%
2017 โ‚น705.40 B-5.27%
2016 โ‚น744.66 B-6.44%
2015 โ‚น795.95 B
2013 โ‚น873.08 B11.45%
2012 โ‚น783.36 B3.6%
2011 โ‚น756.14 B31.99%
2010 โ‚น572.86 B